BHU gets patent on tri-target antiviral activity against SARS CoV2
Tanuja Joshi | June 20, 2023 | 03:20 PM IST | 1 min read
BHU's Centre for Genetic Disorders and Department of Zoology developed a system targeting 3 parts of virus making way for Covid treatment.
NEW DELHI: The Banaras Hindu University (BHU) has received a German patent for its work on the identification of tri-target antiviral activity against the SARS CoV2 virus.
Parimal Das led the team along with researchers from the Centre for Genetic Disorders and the Department of Zoology at the Institute of Science. They have developed a system that targets three crucial proteins of the virus, paving the way for COVID-19 treatment.
ALSO READ| BHU scientists secure permission for German patent for system to inhibit growth of covid virus
Das said, "We are thrilled to have been granted a second international patent for our research on Sominone. This is a significant milestone in our ongoing efforts to combat the SARS CoV2 virus.”
BHU research
The team focused on Sominone, a novel antiviral molecule derived from Aswagandha, which has demonstrated an impressive 96 percent inhibition rate against the SARS CoV2 virus. The researchers worked to uncover the properties of Sominone. This latest achievement will help in antiviral research, specifically in developing effective treatments for COVID-19.
“We hope that our findings will contribute to the development of novel antiviral therapies and ultimately help in the fight against the COVID-19 pandemic.", said Das.
The recently granted German patent shows the team's commitment to the field of antiviral research. This international recognition acknowledges the innovative approach and potential impact of their research, which holds promise for the development of novel antiviral therapies.
ALSO READ| BHU to launch scholarship for economically weak MBBS students
BHU's Centre for Genetic Disorders and Department of Zoology have long been recognized for their research in the fields of molecular biology and genetics. This latest achievement highlights their commitment to scientific excellence and their pursuit of innovative solutions to global health challenges.
Follow us for the latest education news on colleges and universities, admission, courses, exams, research, education policies, study abroad and more..
To get in touch, write to us at news@careers360.com.
Quick Watch
]Featured News
]- SNU Chennai VC: Mechanical, civil, chemical engineering still deliver; demand for BTech cybersecurity on rise
- ‘Bureaucratic hurdle’: KCET rank list not updated after CBSE re-evaluation, affects admission, says student
- How Bihar Engineering University is powering through violence, floods, placement woes
- As tighter immigration norms rub shine off UK, US for Indian MBBS grads, Australia, Germany, Middle East gain
- Maharashtra’s new Class 6 social science textbook drops caste system, meat diet; paints rosy Vedic past
- IIIT Allahabad fines B.Techs who accept campus placement offers and then take other jobs, allege students
- Tamil Nadu: Chennai LKG fees highest in state; fee details of thousands of TN private schools public
- GMR Aero Technic’s aviation course produces professionals airlines can deploy from day one: President
- No more ‘half-baked doctors’: NMC scraps 2-year PG medical diplomas; over 3,300 seats will go to MD, MS
- MBBS interns seek uniform stipend policy as amounts vary wildly and private medical colleges underpay